Incidence of thyroid disorders in systemic sclerosis: Results from a longitudinal follow-up

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 7, 2013, Pages

  Antonelli, Alessandro ^a   Fallahi, Poupak ^a   Ferrari, Silvia Martina ^a   Mancusi, Caterina ^a   Giuggioli, Dilia ^b   Colaci, Michele ^b   Ferri, Clodoveo ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPOTHYROIDISM; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCLERODERMA; THYROID DISEASE; THYROID WEIGHT;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; DIET; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HASHIMOTO DISEASE; HUMANS; INCIDENCE; IODIDE PEROXIDASE; IODINE; IRON-BINDING PROTEINS; ITALY; LOGISTIC MODELS; LONGITUDINAL STUDIES; MIDDLE AGED; ORGAN SIZE; RISK FACTORS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; THYROID GLAND; THYROIDITIS, AUTOIMMUNE; THYROTROPIN;

EID: 84879917881     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3583     Document Type: Article

References (20)

1. Black CM, Denton CP. Scleroderma and related disorders in adults and children. In: Isenberg DA, Maddison PJ, Woo P, Glass D, Breedveld FC, eds. Oxford Textbook of Rheumatology. 3rd ed. Oxford: Oxford Writing Press; 2004;872-895.
2. Ferri C, Valentini G, Cozzi F, et al. Systemic sclerosis: demographic, clinical and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore). 2002;81:139-153. (Pubitemid 34218569)
3. Antonelli A, Ferri C, Fallahi P, et al. Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. Eur J Endocrinol. 2007;156:431-437. (Pubitemid 46672643)
4. Hudson M, Rojas-Villarraga A, Coral-Alvarado P, et al. Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimmun. 2008;31:156-159.
5. Marasini B, Ferrari PA, Solaro N, Selmi C. Thyroid dysfunction in women with systemic sclerosis. Ann NY Acad Sci. 2007;1108:305-311. (Pubitemid 47528743)
6. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581-590.
7. Johnson SR, Fransen J, Khanna D, et al. Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res (Hoboken). 2012;64:358-367.
8. Donati L, Antonelli A, Bertoni F, et al. Clinical picture of endemic cretinism in central Apennines (Montefeltro). Thyroid. 1992;2:283-290. (Pubitemid 23054186)
9. Bournaud C, Orgiazzi JJ. Iodine excess and thyroid autoimmunity. J Endocrinol Invest. 2003;26:49-56.
10. Dunn JT, Crutchfield HE, Gutekunst R, Dunn AD. Two simple methods for measuring iodine in urine. Thyroid. 1993;3:119-123. (Pubitemid 23199734)
11. Antonelli A, Fallahi P, Nesti C, et al. Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease. Clin Exp Immunol. 2001;126:426-431. (Pubitemid 34008713)
12. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43:55-68.
13. Roos A, Links TP, de Jong-van den Berg LT, Gans RO, Wolffenbuttel BH, Bakker SJ. Thyroid peroxidase antibodies, levels of thyroid stimulating hormone and development of hypothyroidism in euthyroid subjects. Eur J Intern Med. 2010;21:555-559.
14. Li Y, Teng D, Shan Z, et al. Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes. J Clin Endocrinol Metab. 2008;93:1751-1757. (Pubitemid 351656514)
15. Romagnani S. The Th1/Th2 paradigm. Immunol Today. 1997;18:263-266. (Pubitemid 27261442)
16. Antonelli A, Rotondi M, Ferrari SM, et al. Interferon-γ-inducible α-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-γ agonists. J Clin Endocrinol Metab. 2006;91:614-620. (Pubitemid 43236933)
17. Valentini G, Baroni A, Esposito K, et al. Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation. J Clin Immunol. 2001;21:210-217. (Pubitemid 32434308)
18. Fujii H, Shimada Y, Hasegawa M, Takehara K, Sato S. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis. J Dermatol Sci. 2004;35:43-51. (Pubitemid 38759740)
19. Antonelli A, Ferri C, Fallahi P, et al. Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis. J Rheumatol. 2008;35:1809-1811.
20. Antonelli A, Ferri C, Fallahi P, et al. CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - a longitudinal study. Rheumatology (Oxford). 2008;47:45-49. (Pubitemid 350286260)